Staff cuts sweep across FDA; Tariff rollout raises questions; The R&D 15 is back; and morenews2025-04-05T10:00:54+00:00April 5th, 2025|Endpoints News|
Trump administration leaves obesity coverage expansion out of new Medicare rulenews2025-04-04T21:10:38+00:00April 4th, 2025|Endpoints News|
GSK and Pfizer resolve RSV vaccine patent fightnews2025-04-04T19:36:29+00:00April 4th, 2025|Endpoints News|
Marks was asked to provide non-existent vaccine risk data: WSJnews2025-04-04T19:03:41+00:00April 4th, 2025|Endpoints News|
Novavax’s approval delay may signal warning for vaccine makersnews2025-04-04T18:49:03+00:00April 4th, 2025|Endpoints News|
China’s retaliatory tariffs on US could mean more headwinds for drugmakersnews2025-04-04T17:25:01+00:00April 4th, 2025|Endpoints News|
States sue NIH over alleged grant cancellations, delaysnews2025-04-04T16:56:15+00:00April 4th, 2025|Endpoints News|
Kennedy team defends Marks firing, while 20% of staff cuts may be ‘mistakes’news2025-04-04T15:41:01+00:00April 4th, 2025|Endpoints News|
RiboX Therapeutics quietly starts first circular RNA trialnews2025-04-04T14:35:13+00:00April 4th, 2025|Endpoints News|
